Yuji Fujii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuji Fujii has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Misuzu Okajima
Joint Graduate School of Veterinary Sciences, Gifu University
6 shared publicationsShoko Nishiyama
Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University
5 shared publicationsFumiki Izumi
Joint Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu, Gifu 501-1193, Japan
4 shared publicationsMakoto Sugiyama
Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University
4 shared publications- Naoto Ito
Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan
4 shared publications Ryota Iwasaki
Animal Medical Center, Gifu University, Gifu, Japan
3 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (4)
Selection and characterization of ssDNA aptamers targeting tick-borne encephalitis virus particles
- 12 October 2026
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (4)
Open AccessSelection and characterization of ssDNA aptamers targeting tick-borne encephalitis virus particles
- Open Access
- 17 September 2026
- Published by Wiley in Journal of Small Animal Practice
A dose‐escalated radiation protocol of 10 × 4.0 Gy provides long‐term local control in canine apocrine gland anal sac adenocarcinoma
Objectives: To obtain insights for establishing radiation therapy strategies that provide long‐term locoregional benefits in canine apocrine gland anal sac adenocarcinoma, we evaluated whether a dose‐escalated protocol (10 × 4.0 Gy) could improve clinical outcomes, particularly long‐term locoregional control, while maintaining acceptable toxicity. Materials and Methods: This retrospective cohort study included dogs with apocrine gland anal sac adenocarcinoma treated with three‐dimensional conformal radiation therapy between September 2016 and September 2025. Dogs administered chemotherapy agents other than toceranib phosphate were excluded. Dogs were classified according to the radiation therapy protocol received as the dose‐escalated protocol group (10 × 4.0 Gy; Group A, n = 15) or the comparison group (8 × 3.8 Gy; Group B, n = 11). Outcomes included overall survival, progression‐free survival, local progression‐free survival and radiation‐related adverse effects. Results: The median overall survival, progression‐free survival and local progression‐free survival of Group A (1534, 926 and 1554 days, respectively) were significantly longer than those of Group B (821, 258 and 351 days, respectively). The treatment response rate based on the 3‐month follow‐up CT examination was higher in Group A (90.9%) than in Group B (10.0%). The 1‐year local progression‐free survival rate was also higher in Group A (93.3%) than in Group B (45.5%). Additionally, all observed radiation‐related adverse effects were clinically manageable. Clinical Significance: This retrospective cohort study demonstrated that the dose‐escalated 10 × 4.0 Gy protocol was associated with improved locoregional control and clinically manageable toxicity. Our findings suggest that dose escalation in apocrine gland anal sac adenocarcinoma therapy can be an effective strategy when sustained locoregional control is a clinical priority.
- 17 September 2026
- Published by Wiley in Journal of Small Animal Practice
Open AccessA dose‐escalated radiation protocol of 10 × 4.0 Gy provides long‐term local control in canine apocrine gland anal sac adenocarcinoma
Objectives: To obtain insights for establishing radiation therapy strategies that provide long‐term locoregional benefits in canine apocrine gland anal sac adenocarcinoma, we evaluated whether a dose‐escalated protocol (10 × 4.0 Gy) could improve clinical outcomes, particularly long‐term locoregional control, while maintaining acceptable toxicity. Materials and Methods: This retrospective cohort study included dogs with apocrine gland anal sac adenocarcinoma treated with three‐dimensional conformal radiation therapy between September 2016 and September 2025. Dogs administered chemotherapy agents other than toceranib phosphate were excluded. Dogs were classified according to the radiation therapy protocol received as the dose‐escalated protocol group (10 × 4.0 Gy; Group A, n = 15) or the comparison group (8 × 3.8 Gy; Group B, n = 11). Outcomes included overall survival, progression‐free survival, local progression‐free survival and radiation‐related adverse effects. Results: The median overall survival, progression‐free survival and local progression‐free survival of Group A (1534, 926 and 1554 days, respectively) were significantly longer than those of Group B (821, 258 and 351 days, respectively). The treatment response rate based on the 3‐month follow‐up CT examination was higher in Group A (90.9%) than in Group B (10.0%). The 1‐year local progression‐free survival rate was also higher in Group A (93.3%) than in Group B (45.5%). Additionally, all observed radiation‐related adverse effects were clinically manageable. Clinical Significance: This retrospective cohort study demonstrated that the dose‐escalated 10 × 4.0 Gy protocol was associated with improved locoregional control and clinically manageable toxicity. Our findings suggest that dose escalation in apocrine gland anal sac adenocarcinoma therapy can be an effective strategy when sustained locoregional control is a clinical priority.
- Open Access
- 15 April 2025
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (4) , e0208224
Functional dissection of the C-terminal domain of rabies virus RNA polymerase L protein
The rabies virus large (L) protein interacts with its cofactor phosphoprotein (P protein) to function as an RNA-dependent RNA polymerase (RdRp). The C-terminal domain (CTD) of the L protein plays a critical role in P protein binding. We previously reported that the highly conserved NPYNE sequence in the hydrophilic region of the CTD (positions 1929–1933 of the L protein [L1929–1933]) is important for both P protein binding and RdRp function. To elucidate the functional role of the CTD in detail, we examined the importance of each of the hydrophilic residues in the N PY NE sequence (underlined). A rabies virus mutant with Ala substitutions in these hydrophilic residues showed low replication capacity. Comprehensive analyses of a revertant of the mutant virus and a series of L protein mutants revealed that Asn at L1929 is crucial for both P protein binding and RdRp function. Analyses of the L protein mutants also showed that Asn at L1932 and Glu at L1933 have roles in RdRp function and P protein binding, respectively. Furthermore, we demonstrated that the NPYNE sequence is essential for stabilizing the L protein through the L-P interaction. In a previously determined L protein structure, all of the hydrophilic residues in the NPYNE sequence form the first α-helix in the CTD. Therefore, our findings indicate that this helix is important for P protein-binding ability, RdRp function, and stabilization of the L protein, thereby contributing to efficient viral replication. IMPORTANCE: Although RNA-dependent RNA polymerase of rhabdoviruses, which is composed of the large (L) protein and its cofactor phosphoprotein (P protein), has a high potential as a target for therapeutics against the viruses, the relationship between the structure and molecular functions is poorly understood. In this study, we functionally examined the C-terminal domain (CTD) of the rabies virus L protein as a model for the rhabdovirus L protein. We showed that the first α-helix in the CTD is important for the P protein-binding ability, RdRp function, and stability of the L protein. Since in the L-P complex structure, this helix does not form an interface with the P protein, we provide here the first evidence of an indirect contribution of the L protein CTD to the L-P interaction in rhabdoviruses. The findings in this study will be useful for developing therapeutics targeting the L-P interaction.
- 15 April 2025
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (4) , e0208224
Open AccessFunctional dissection of the C-terminal domain of rabies virus RNA polymerase L protein
The rabies virus large (L) protein interacts with its cofactor phosphoprotein (P protein) to function as an RNA-dependent RNA polymerase (RdRp). The C-terminal domain (CTD) of the L protein plays a critical role in P protein binding. We previously reported that the highly conserved NPYNE sequence in the hydrophilic region of the CTD (positions 1929–1933 of the L protein [L1929–1933]) is important for both P protein binding and RdRp function. To elucidate the functional role of the CTD in detail, we examined the importance of each of the hydrophilic residues in the N PY NE sequence (underlined). A rabies virus mutant with Ala substitutions in these hydrophilic residues showed low replication capacity. Comprehensive analyses of a revertant of the mutant virus and a series of L protein mutants revealed that Asn at L1929 is crucial for both P protein binding and RdRp function. Analyses of the L protein mutants also showed that Asn at L1932 and Glu at L1933 have roles in RdRp function and P protein binding, respectively. Furthermore, we demonstrated that the NPYNE sequence is essential for stabilizing the L protein through the L-P interaction. In a previously determined L protein structure, all of the hydrophilic residues in the NPYNE sequence form the first α-helix in the CTD. Therefore, our findings indicate that this helix is important for P protein-binding ability, RdRp function, and stabilization of the L protein, thereby contributing to efficient viral replication. IMPORTANCE: Although RNA-dependent RNA polymerase of rhabdoviruses, which is composed of the large (L) protein and its cofactor phosphoprotein (P protein), has a high potential as a target for therapeutics against the viruses, the relationship between the structure and molecular functions is poorly understood. In this study, we functionally examined the C-terminal domain (CTD) of the rabies virus L protein as a model for the rhabdovirus L protein. We showed that the first α-helix in the CTD is important for the P protein-binding ability, RdRp function, and stability of the L protein. Since in the L-P complex structure, this helix does not form an interface with the P protein, we provide here the first evidence of an indirect contribution of the L protein CTD to the L-P interaction in rhabdoviruses. The findings in this study will be useful for developing therapeutics targeting the L-P interaction.
- Open Access
- 12 November 2024
- Published by MDPI AG in Veterinary Sciences
- Vol. 11 (11) , 559
The First Case of a Cat Infected with Burkholderia pseudomultivorans, a Member of the Burkholderia cepacia Complex
The Burkholderia cepacia complex (Bcc) is a group of bacteria with similar biological properties which are an important cause of opportunistic infections. Identification of the Bcc species is important to understand clinical outcomes in human patients. However, there are few studies of Bcc species infecting companion animals such as cats. This report shows for the first time an infection with B. pseudomultivorans, a member of Bcc, in veterinary medicine. A 9-year-old, FIV-positive, mixed-breed cat was subjected to immunosuppressive therapy, developed septic shock, and died. In the bone marrow specimen collected postmortem, numerous short bacilli—some of which were phagocytosed by leukocytes—were observed. By bacteriological examination, the Bcc-like bacteria were isolated from the bone marrow sample. Genetic analysis showed that the recA gene sequence detected from the present case exhibited the highest homology (98–100%) to that of B. pseudomultivorans. Based on these examinations, the present case was diagnosed as B. pseudomultivorans infection. The findings of this study highlight the need for investigation of the Bcc species in veterinary practice to help in treatment decisions and the prognostic evaluation of Bcc infections.
- 12 November 2024
- Published by MDPI AG in Veterinary Sciences
- Vol. 11 (11) , 559
Open AccessThe First Case of a Cat Infected with Burkholderia pseudomultivorans, a Member of the Burkholderia cepacia Complex
The Burkholderia cepacia complex (Bcc) is a group of bacteria with similar biological properties which are an important cause of opportunistic infections. Identification of the Bcc species is important to understand clinical outcomes in human patients. However, there are few studies of Bcc species infecting companion animals such as cats. This report shows for the first time an infection with B. pseudomultivorans, a member of Bcc, in veterinary medicine. A 9-year-old, FIV-positive, mixed-breed cat was subjected to immunosuppressive therapy, developed septic shock, and died. In the bone marrow specimen collected postmortem, numerous short bacilli—some of which were phagocytosed by leukocytes—were observed. By bacteriological examination, the Bcc-like bacteria were isolated from the bone marrow sample. Genetic analysis showed that the recA gene sequence detected from the present case exhibited the highest homology (98–100%) to that of B. pseudomultivorans. Based on these examinations, the present case was diagnosed as B. pseudomultivorans infection. The findings of this study highlight the need for investigation of the Bcc species in veterinary practice to help in treatment decisions and the prognostic evaluation of Bcc infections.
- 8 August 2023
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 30 (11) , 1524-1529
Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors
Malignant melanoma (MM) is one of the most common tumors in both dogs and humans. As canine MM (CMM) and human MM (HMM) have similar clinical characteristics, CMM appears to be a good clinical model for HMM. We previously demonstrated that the introduction of a synthetic double-strand-microRNA-634 (miR-634) mimic triggered apoptotic cell death by directly targeting the genes associated with cytoprotective processes in various human cancer cell lines, including those of HMM. This study aimed to investigate the antitumor effects of the local administration of miR-634 on spontaneous CMMs to provide a basis for future applications of miR-634 formulations in HMM treatment. We found that miR-634 administration induced apoptosis in CMM cell lines in vitro via downregulation of Asct2, Nrf2, and survivin expression, similar to the mechanisms in HMM cell lines. Furthermore, intratumoral miR-634 administration induced antitumor effects in four of seven spontaneous CMM cases, with no adverse effects. Local administration of miR-634 to lung metastasis under ultrasound guidance induced tumor shrinkage. These results confirm the antitumor effect of the local administration of miR-634 in spontaneous CMM, a model for spontaneous HMM, thereby providing a novel treatment strategy for HMM.
- 8 August 2023
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 30 (11) , 1524-1529
Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors
Malignant melanoma (MM) is one of the most common tumors in both dogs and humans. As canine MM (CMM) and human MM (HMM) have similar clinical characteristics, CMM appears to be a good clinical model for HMM. We previously demonstrated that the introduction of a synthetic double-strand-microRNA-634 (miR-634) mimic triggered apoptotic cell death by directly targeting the genes associated with cytoprotective processes in various human cancer cell lines, including those of HMM. This study aimed to investigate the antitumor effects of the local administration of miR-634 on spontaneous CMMs to provide a basis for future applications of miR-634 formulations in HMM treatment. We found that miR-634 administration induced apoptosis in CMM cell lines in vitro via downregulation of Asct2, Nrf2, and survivin expression, similar to the mechanisms in HMM cell lines. Furthermore, intratumoral miR-634 administration induced antitumor effects in four of seven spontaneous CMM cases, with no adverse effects. Local administration of miR-634 to lung metastasis under ultrasound guidance induced tumor shrinkage. These results confirm the antitumor effect of the local administration of miR-634 in spontaneous CMM, a model for spontaneous HMM, thereby providing a novel treatment strategy for HMM.
- Open Access
- 27 January 2023
- Published by Springer Nature in Research Square
Therapeutic applications of topical injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors
Malignant melanoma (MM) is one of the most common tumors in both dogs and humans. As canine MM (CMM) and human MM (HMM) have similar clinical characteristics, CMM appears to be a good clinical model for HMM. We previously demonstrated that the introduction of a synthetic double-strand-microRNA-634 (miR-634) mimic triggered apoptotic cell death by directly targeting the genes associated with cytoprotective processes in various human cancer cell lines, including those of HMM. This study aimed to investigate the antitumor effects of topical administration of miR-634 on spontaneous CMMs to provide a basis for future applications of miR-634 formulations in HMM treatment. We found that miR-634 administration induced apoptosis in CMM cell lines in vitro via downregulation of Asct2, Nrf2, and survivin expression, similar to the mechanisms in HMM cell lines. Furthermore, intratumoral miR-634 administration induced antitumor effects in four of seven spontaneous CMM cases, with no adverse effects. Local administration of miR-634 to lung metastasis under ultrasound guidance induced tumor shrinkage. These results confirm the antitumor effect of topical administration of miR-634 in spontaneous CMM, a model for spontaneous HMM, thereby providing a novel treatment strategy for HMM.
- 27 January 2023
- Published by Springer Nature in Research Square
Open AccessTherapeutic applications of topical injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors
Malignant melanoma (MM) is one of the most common tumors in both dogs and humans. As canine MM (CMM) and human MM (HMM) have similar clinical characteristics, CMM appears to be a good clinical model for HMM. We previously demonstrated that the introduction of a synthetic double-strand-microRNA-634 (miR-634) mimic triggered apoptotic cell death by directly targeting the genes associated with cytoprotective processes in various human cancer cell lines, including those of HMM. This study aimed to investigate the antitumor effects of topical administration of miR-634 on spontaneous CMMs to provide a basis for future applications of miR-634 formulations in HMM treatment. We found that miR-634 administration induced apoptosis in CMM cell lines in vitro via downregulation of Asct2, Nrf2, and survivin expression, similar to the mechanisms in HMM cell lines. Furthermore, intratumoral miR-634 administration induced antitumor effects in four of seven spontaneous CMM cases, with no adverse effects. Local administration of miR-634 to lung metastasis under ultrasound guidance induced tumor shrinkage. These results confirm the antitumor effect of topical administration of miR-634 in spontaneous CMM, a model for spontaneous HMM, thereby providing a novel treatment strategy for HMM.
- Open Access
- 12 October 2022
- Published by Microbiology Society in Journal of General Virology
- Vol. 103 (10) , 001792
Molecular characterisation of a novel avian rotavirus A strain detected from a gull species (Larus sp.)
A recent study demonstrated the possibility that migratory birds are responsible for the global spread of avian rotavirus A (RVA). However, little is known about what types of RVAs are retained in migratory birds. In this study, to obtain information on RVA strains in migratory birds, we characterised an RVA strain, Ho374, that was detected in a faecal sample from a gull species (Larus sp.). Genetic analysis revealed that all 11 genes of this strain were classified as new genotypes (G28-P[39]-I21-R14-C14-M13-A24-N14-T16-E21-H16). This clearly indicates that the genetic diversity of avian RVAs is greater than previously recognised. Our findings highlight the need for investigations of RVA strains retained in migratory birds, including gulls.
- 12 October 2022
- Published by Microbiology Society in Journal of General Virology
- Vol. 103 (10) , 001792
Open AccessMolecular characterisation of a novel avian rotavirus A strain detected from a gull species (Larus sp.)
A recent study demonstrated the possibility that migratory birds are responsible for the global spread of avian rotavirus A (RVA). However, little is known about what types of RVAs are retained in migratory birds. In this study, to obtain information on RVA strains in migratory birds, we characterised an RVA strain, Ho374, that was detected in a faecal sample from a gull species (Larus sp.). Genetic analysis revealed that all 11 genes of this strain were classified as new genotypes (G28-P[39]-I21-R14-C14-M13-A24-N14-T16-E21-H16). This clearly indicates that the genetic diversity of avian RVAs is greater than previously recognised. Our findings highlight the need for investigations of RVA strains retained in migratory birds, including gulls.
- 20 June 2022
- Published by Wiley in Animal Genetics
- Vol. 53 (5) , 696-699
A frameshift variant in the EXT1 gene in a feline leukemia virus‐negative cat with osteochondromatosis
Osteochondromatosis is a benign proliferative disorder characterized by cartilage-capped bony protuberances. In humans and most mammals, variants in the EXT1 or EXT2 gene are strongly correlated with the etiology of osteochondromatosis. However, in cats, osteochondromatosis has only been associated with feline leukemia virus infection. In this study, to explore other factors involved in the etiology of feline osteochondromatosis, we examined the EXT1 and EXT2 genes in a feline leukemia virus-negative cat with osteochondromatosis. Genetic analysis revealed a heterozygous single base pair duplication in exon 6 of the EXT1 gene (XM_023248762.2:c.1468dupC), leading to a premature stop codon in the EXT1 protein. Notably, this frameshift variant is recognized as one of the most common pathogenic variants in human osteochondromatosis. Our data suggest for the first time that genetic variants can have etiologic roles in osteochondromatosis in cats, as in humans and other animals.
- 20 June 2022
- Published by Wiley in Animal Genetics
- Vol. 53 (5) , 696-699
A frameshift variant in the EXT1 gene in a feline leukemia virus‐negative cat with osteochondromatosis
Osteochondromatosis is a benign proliferative disorder characterized by cartilage-capped bony protuberances. In humans and most mammals, variants in the EXT1 or EXT2 gene are strongly correlated with the etiology of osteochondromatosis. However, in cats, osteochondromatosis has only been associated with feline leukemia virus infection. In this study, to explore other factors involved in the etiology of feline osteochondromatosis, we examined the EXT1 and EXT2 genes in a feline leukemia virus-negative cat with osteochondromatosis. Genetic analysis revealed a heterozygous single base pair duplication in exon 6 of the EXT1 gene (XM_023248762.2:c.1468dupC), leading to a premature stop codon in the EXT1 protein. Notably, this frameshift variant is recognized as one of the most common pathogenic variants in human osteochondromatosis. Our data suggest for the first time that genetic variants can have etiologic roles in osteochondromatosis in cats, as in humans and other animals.